Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 57

1.

Staging cancer of the pancreas.

Morana G, Cancian L, Pozzi Mucelli R, Cugini C.

Cancer Imaging. 2010 Oct 4;10 Spec no A:S137-41. doi: 10.1102/1470-7330.2010.9028. Review.

2.

A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.

Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT.

Ann Surg. 2009 Dec;250(6):957-63. doi: 10.1097/SLA.0b013e3181b2fafa.

PMID:
19687736
3.

Positron emission tomography/computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness.

Heinrich S, Goerres GW, Schäfer M, Sagmeister M, Bauerfeind P, Pestalozzi BC, Hany TF, von Schulthess GK, Clavien PA.

Ann Surg. 2005 Aug;242(2):235-43.

4.

[Retroactive evaluation of perioperative staging and surgical decision making for patients with pancreatic cancer].

Wang CY.

Zhonghua Wai Ke Za Zhi. 2007 Jan 1;45(1):3-5. Review. Chinese. No abstract available.

PMID:
17403279
5.

Pancreatic cancer: current concepts in imaging for diagnosis and staging.

Tamm E, Charnsangavej C.

Cancer J. 2001 Jul-Aug;7(4):298-311. Review.

PMID:
11561606
6.

18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.

Sperti C, Bissoli S, Pasquali C, Frison L, Liessi G, Chierichetti F, Pedrazzoli S.

Ann Surg. 2007 Dec;246(6):932-7; discussion 937-9.

PMID:
18043094
7.

Imaging of neuroendocrine tumors.

Tamm EP, Kim EE, Ng CS.

Hematol Oncol Clin North Am. 2007 Jun;21(3):409-32; vii. Review.

PMID:
17548032
8.

Intraductal oncocytic papillary neoplasm of the pancreas: a radio-pathological case study.

Fischer MA, Donati O, Heinrich S, Weber A, Hany TF, Soldini D, Alkadhi H, Marincek B, Scheffel H.

JOP. 2010 Jan 8;11(1):49-54.

9.

Preoperative staging and assessment of resectability of pancreatic cancer.

Warshaw AL, Gu ZY, Wittenberg J, Waltman AC.

Arch Surg. 1990 Feb;125(2):230-3.

PMID:
2154172
10.

Imaging of pancreatic adenocarcinoma: update on staging/resectability.

Tamm EP, Balachandran A, Bhosale PR, Katz MH, Fleming JB, Lee JH, Varadhachary GR.

Radiol Clin North Am. 2012 May;50(3):407-28. doi: 10.1016/j.rcl.2012.03.008. Epub 2012 Apr 6. Review.

PMID:
22560689
11.

Pancreatic metastasis detected by F-18 FDG PET/CT in a patient with breast cancer.

Lam WW, Loke KS, Loi HY, Padhy AK.

Clin Nucl Med. 2011 Jun;36(6):479-80. doi: 10.1097/RLU.0b013e31820adf47.

PMID:
21552032
12.

Synchronous quadruple primary tumors of thyroid, breast, pancreas, and stomach: a case report.

Kim JS, Chung CY, Park HC, Myung DS, Cho SB, Lee WS, Min JJ, Joo YE.

Anticancer Res. 2013 May;33(5):2135-8.

PMID:
23645766
13.

Recent advances in imaging of pancreatic neoplasms.

Rabinowitz CB, Prabhakar HB, Sahani DV.

Cancer Treat Res. 2008;143:229-54. Review. No abstract available.

PMID:
18619220
14.

How useful is integrated PET and CT for the management of pancreatic cancer?

Hamer OW, Feuerbach S.

Nat Clin Pract Gastroenterol Hepatol. 2006 Feb;3(2):74-5. No abstract available.

PMID:
16456571
15.

[The current state of radiologic diagnosis in pancreatic cancer].

Nesterov DV, Rozengauz EV.

Vopr Onkol. 2014;60(5):553-62. Review. Russian.

PMID:
25816658
16.

Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma.

Pfannenberg C, Aschoff P, Schanz S, Eschmann SM, Plathow C, Eigentler TK, Garbe C, Brechtel K, Vonthein R, Bares R, Claussen CD, Schlemmer HP.

Eur J Cancer. 2007 Feb;43(3):557-64. Epub 2007 Jan 16.

PMID:
17224266
17.

PET/CT imaging in the diagnosis, staging, and follow-up of colorectal cancer.

Vikram R, Iyer RB.

Cancer Imaging. 2008 Oct 4;8 Spec No A:S46-51. doi: 10.1102/1470-7330.2008.9009. Review.

18.

Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results.

Nomori H, Mori T, Ikeda K, Kawanaka K, Shiraishi S, Katahira K, Yamashita Y.

J Thorac Cardiovasc Surg. 2008 Apr;135(4):816-22. doi: 10.1016/j.jtcvs.2007.10.035.

19.
20.

FDG-PET/CT identifies a curable pancreatic cancer surgical tract metastasis after failure by other imaging modalities.

Lachter J, Adler AC, Keidar Z, Haddad R.

Isr Med Assoc J. 2008 Mar;10(3):243-4. No abstract available.

Supplemental Content

Support Center